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Background
The mechanisms of how sexual violence affects women’s risk for HIV
remains unclear. Women are more likely to be affected by HIV/AIDS, as
over 50% of all HIV infections were in women, particularly in young
women1. Women are also disproportionately affected by sexual
violence. In the United States alone, sexual assault is the sixth leading
cause of injury in women2. Three longitudinal studies from Africa, for
example, showed that intimate partner violence was associated with a
50% increase in HIV infection1.

Results

Conclusions

Fig. 1: Differential expression of biomarkers in Cases vs. Controls

Increased HIV acquisition has been shown to be associated with
inflammation in the genital tract3. Previous studies have also shown
that there was a significant association between sexual assault and
genital immune biomarkers linked to inflammation in women who
experience life-long chronic sexual violence2.
This study will evaluate the following biomarkers in survivors of acute
sexual violence: cytokines interleukin 1 alpha (IL-1ɑ), interleukin 1 beta
(IL-1β), tumor necrosis factor alpha (TNF-ɑ), and interleukin 6 (IL-6), and
chemokine macrophage inflammatory protein-3 (MIP-3ɑ). IL-1ɑ is a
primary cytokine involved in the production of inflammation4. IL-1β is a
mediator of that inflammatory response and is involved in immune cell
proliferation, differentiation, and apoptosis4. TNF-ɑ is also involved in
the systemic inflammation and the acute phase reaction, and it is an
important regulator of immune cells4. IL-6 is both a pro-inflammatory
and anti-inflammatory cytokine; it mediates fever and the acute phase
response, which is a part of the body’s innate immune
response4. MIP3ɑ attracts lymphocytes and is a known anti-HIV factor5.

Future Directions

Fig. 2: Changes in biomarkers based on time after assault

Table 1: Demographic Information

Methods
Recruitment: Cases were collected from the Women and Infants
Hospital of Rhode Island (WIHR) from women who experienced sexual
assault within 5 days before their first visit to the clinic. Controls were
taken from a previous study and were women recruited from the
Washington D.C. metro community who have never experienced sexual
assault.
Enzyme-Linked Immunosorbent Assay (ELISA): Cervicovaginal lavage
(CVL) samples were collected. Each sample was tested in triplicate for
IL-1ɑ, IL-1β, TNF-ɑ, IL-6, and MIP-3ɑ according to manufacturer ’s
protocol (R&D Systems).
Statistical Analysis: Median values of IL-1ɑ, IL-1β, TNF-ɑ, IL-6, and
MIP-3ɑ of the cases and controls were compared using Mann-Whitney
U test. The hour of the first clinic visit after the assault for each
biomarker were compared to each other using Kruskal-Wallis ANOVA
test. Graphs were created using Graphpad PRISM.

• Measure expression and perform statistical analysis of antiinflammatory and wound-healing biomarkers.
• Understand mechanisms of wound-healing through in vitro cell
culture-based model for TNF-⍺, IL-1 ⍺, and IL-1β.
• Compare these results to other sexual assault studies with
chronic and non-acute survivors .
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Objectives
The principal aim of this study is to investigate the levels of genital
inflammatory biomarkers in survivors of acute sexual assault violence. It
is hypothesized that there will be an increase in biomarkers levels in
Cases compared to Controls and inflammation will be highest
immediately after assault.

• Significant changes in inflammatory biomarkers IL-1 ⍺, IL-1β,
and TNF-⍺ between cases and controls. IL-1 ⍺ and IL-1β were
increased, while TNF-⍺ was decreased,
• Significant changes in IL-1⍺ and IL-6 when comparing the hour
of arrival to the clinic after the assault. IL-1⍺ and IL-6 were
increased in the 0-12 hours compared to the 13-24 hours and
the 25-72 hours.
• This finding suggests an immediate inflammatory immune
response following a sexual assault, which has the potential of
increasing HIV risk in these women.

Table 2: Differences in Biomarkers
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